As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

"Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients" was originally created and published by ...

Fireside Ventures appoints Adarsh Menon as Operating Partner Fireside Ventures, an early-stage venture fund investing in ...

Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...

Early-stage venture capital firm Fireside Ventures has roped in a former Flipkart executive as an operating partner to ...

Under his leadership, the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK, Hero ...

Other notable outperformers include FDC (9.5%), Eris Lifesciences Ltd. (8.6%), Alkem Laboratories Ltd. (7.2%), Abbott India ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...